🔗 Share this article Users Stopping Weight-Loss Medications Gain Back Pounds Far More Rapidly Than People Using Diet and Exercise Weight management involves ongoing approaches. A recent study indicates that people who stop using blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens. Findings released in a leading medical journal shows that while obese individuals often shed substantial amounts of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Individuals purchasing these treatments should be cognizant of the potential of fast weight regain when the medication concludes," cautioned expert Dr. Susan Jebb. That rate of regain suggests a reversion to original mass within about 18 months. Analyzing Approaches The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods. The team note that people who lose weight through diet and exercise typically see a less rapid weight regain—approximately 100 grams monthly—post-intervention. Understanding the Quick Rebound Doctors suggest the way of the injections is key to understanding the accelerated rebound. The injections copy a natural hormone called GLP-1, which controls appetite. "Long-term administration of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist. "Stopping of this hormone supplement means hunger is uncontrolled, making binge eating much more probable." A Lifelong Issue? Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications. Many experts argue that, considering the likelihood of relapse, the treatment might need to be long-term. This opinion is echoed by drug manufacturers, who say that the findings "underscore the chronic character of obesity," similar to managing conditions like hypertension. User Accounts Users who have discontinued the jabs report a sudden return of cravings. "It was like a switch activating and you're instantly ravenous," recalled a patient. This challenge is compounded if patients have not developed sustainable lifestyle or habit changes during therapy. Widespread Use Survey data show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow. Adoption is more common among women than men. The 40s and 50s demographic shows the highest level of interest. A large proportion access the medications through private healthcare rather than public health services. Finally, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on combined lifestyle changes.
Weight management involves ongoing approaches. A recent study indicates that people who stop using blockbuster weight-loss injections like Wegovy and Mounjaro may regain reduced body mass at a significantly accelerated pace than those who stop conventional diet and exercise regimens. Findings released in a leading medical journal shows that while obese individuals often shed substantial amounts of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month upon discontinuation. "Individuals purchasing these treatments should be cognizant of the potential of fast weight regain when the medication concludes," cautioned expert Dr. Susan Jebb. That rate of regain suggests a reversion to original mass within about 18 months. Analyzing Approaches The analysis, which reviewed dozens of trials involving thousands of patients, compared the outcomes of GLP-1 agonists with older methods. The team note that people who lose weight through diet and exercise typically see a less rapid weight regain—approximately 100 grams monthly—post-intervention. Understanding the Quick Rebound Doctors suggest the way of the injections is key to understanding the accelerated rebound. The injections copy a natural hormone called GLP-1, which controls appetite. "Long-term administration of the hormone levels far above than normal may cause the system to produce less of its own natural hormone, and may also diminish responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist. "Stopping of this hormone supplement means hunger is uncontrolled, making binge eating much more probable." A Lifelong Issue? Health authorities recommend the jabs for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications. Many experts argue that, considering the likelihood of relapse, the treatment might need to be long-term. This opinion is echoed by drug manufacturers, who say that the findings "underscore the chronic character of obesity," similar to managing conditions like hypertension. User Accounts Users who have discontinued the jabs report a sudden return of cravings. "It was like a switch activating and you're instantly ravenous," recalled a patient. This challenge is compounded if patients have not developed sustainable lifestyle or habit changes during therapy. Widespread Use Survey data show that millions of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow. Adoption is more common among women than men. The 40s and 50s demographic shows the highest level of interest. A large proportion access the medications through private healthcare rather than public health services. Finally, researchers emphasize that while GLP-1 drugs are effective agents for shedding pounds, they are not a permanent solution and lasting health benefits relies on combined lifestyle changes.